The role of PPAR-α agonists in the prevention of CVD in diabetes Marja-Riitta Taskinen Invited Commentary 27 April 2007 Pages: 83 - 85
On the way to a diabetes cure? Improvement of glycemic control through islet transplantation with the use of a standardized common protocol Anette -G. Ziegler Clinical Trials Report 27 April 2007 Pages: 89 - 90
Mucosal exposure to antigen: Cause or cure of type 1 diabetes? Georgia FousteriMatthias von HerrathDamien Bresson OriginalPaper 27 April 2007 Pages: 91 - 98
Randomized controlled clinical trials of psychological interventions to improve glycemic control in pediatric and adult patients with T1DM Barbara J. Anderson Clinical Trials Report 27 April 2007 Pages: 101 - 103
Technology and intensive management in youth with type 1 diabetes: State of the art Jamie R. WoodLori M. B. Laffel OriginalPaper 27 April 2007 Pages: 104 - 113
Recent advances in understanding depression in adults with diabetes Patrick J. LustmanSue M. PenckoferRay E. Clouse OriginalPaper 27 April 2007 Pages: 114 - 122
Efficacy of lifestyle behavior change programs in diabetes Elizabeth M. Venditti OriginalPaper 27 April 2007 Pages: 123 - 127
Insights on pathogenesis of type 2 diabetes from MODY genetics Michael N. WeedonTimothy M. Frayling OriginalPaper 27 April 2007 Pages: 131 - 138
Gene discovery in diabetic nephropathy David A. SavageStephen C. BainA. Peter Maxwell OriginalPaper 27 April 2007 Pages: 139 - 145
The biology of RAGE and its ligands: Uncovering mechanisms at the heart of diabetes and its complications Shi Fang YanGaetano R. BarileAnn Marie Schmidt OriginalPaper 27 April 2007 Pages: 146 - 153
The search for type 2 diabetes susceptibility loci: The chromosome 1q story Swapan Kumar DasSteven C. Elbein OriginalPaper 27 April 2007 Pages: 154 - 164
